对1型神经纤维瘤病患者进行密切随访可降低恶性外周神经鞘膜瘤的发病率。
Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour.
作者信息
Iasella Maria Pia, Ruttens Dries, Hompes Daphne, Vandecaveye Vincent, Sciot Raf, Deroose Christophe, Douchy Thomas, Decramer Thomas, Jacobs Sandra, Denayer Ellen, Van Calenbergh Frank, Legius Eric, Brems Hilde
机构信息
Centre for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium.
Department of Paediatric Oncology, University Hospitals Leuven, 3000 Leuven, Belgium.
出版信息
Cancers (Basel). 2025 Apr 12;17(8):1306. doi: 10.3390/cancers17081306.
Abstract
Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic condition with a birth incidence of one in 2000 to one in 3000 [...].
摘要
1型神经纤维瘤病（NF1）是一种常染色体显性遗传病，出生发病率为2000分之一至3000分之一[...]。
相似文献
1
Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour.
Cancers (Basel). 2025 Apr 12;17(8):1306. doi: 10.3390/cancers17081306.
2
Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1.
J Med Genet. 2007 Jul;44(7):463-6. doi: 10.1136/jmg.2006.048140. Epub 2007 Feb 27.
3
4
Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.
Anticancer Res. 2005 May-Jun;25(3A):1699-702.
5
Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
J Neurosurg. 2017 Jan;126(1):319-329. doi: 10.3171/2015.12.JNS152443. Epub 2016 Apr 1.
6
Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI.
Neurooncol Adv. 2024 Feb 9;6(1):vdae021. doi: 10.1093/noajnl/vdae021. eCollection 2024 Jan-Dec.
7
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1.
Neuro Oncol. 2025 Mar 7;27(3):616-624. doi: 10.1093/neuonc/noae235.
8
Atypical Neurofibromatous Neoplasm with Uncertain Biologic Potential in the Posterior Mediastinum of a Young Patient with Neurofibromatosis Type 1: A Case Report.
Case Rep Oncol. 2022 Nov 8;15(3):988-994. doi: 10.1159/000526844. eCollection 2022 Sep-Dec.
9
Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management.
Cancers (Basel). 2023 Feb 8;15(4):1077. doi: 10.3390/cancers15041077.
10
Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.
Int J Mol Sci. 2024 Aug 27;25(17):9265. doi: 10.3390/ijms25179265.
本文引用的文献
1
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.
Nat Med. 2025 Jan;31(1):105-115. doi: 10.1038/s41591-024-03361-4. Epub 2025 Jan 6.
2
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1.
Neuro Oncol. 2025 Mar 7;27(3):616-624. doi: 10.1093/neuonc/noae235.
3
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.
Clin Cancer Res. 2024 Oct 1;30(19):4363-4376. doi: 10.1158/1078-0432.CCR-24-0797.
4
Advanced Imaging in the Diagnosis and Response Assessment of High-Grade Glioma: Expert Panel Narrative Review.
AJR Am J Roentgenol. 2025 Jan;224(1):e2330612. doi: 10.2214/AJR.23.30612. Epub 2025 Jan 8.
5
Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis.
Clin Cancer Res. 2023 Sep 15;29(18):3744-3758. doi: 10.1158/1078-0432.CCR-22-2462.
6
CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.
Clin Cancer Res. 2023 Sep 1;29(17):3484-3497. doi: 10.1158/1078-0432.CCR-23-0749.
7
Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management.
Cancers (Basel). 2023 Feb 8;15(4):1077. doi: 10.3390/cancers15041077.
8
MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors.
Clin Cancer Res. 2023 Apr 14;29(8):1592-1604. doi: 10.1158/1078-0432.CCR-22-3722.
9
ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.
EClinicalMedicine. 2023 Jan 13;56:101818. doi: 10.1016/j.eclinm.2022.101818. eCollection 2023 Feb.
10
Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI.
Neurology. 2023 Feb 14;100(7):e661-e670. doi: 10.1212/WNL.0000000000201535. Epub 2022 Nov 4.
Zotero 插件